1. Home
  2. SDGR vs PLSE Comparison

SDGR vs PLSE Comparison

Compare SDGR & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Schrodinger Inc.

SDGR

Schrodinger Inc.

HOLD

Current Price

$14.90

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo Pulse Biosciences Inc (DE)

PLSE

Pulse Biosciences Inc (DE)

HOLD

Current Price

$14.39

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SDGR
PLSE
Founded
1990
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
2020
2016

Fundamental Metrics

Financial Performance
Metric
SDGR
PLSE
Price
$14.90
$14.39
Analyst Decision
Buy
Buy
Analyst Count
9
1
Target Price
$24.33
$22.00
AVG Volume (30 Days)
960.8K
167.2K
Earning Date
02-25-2026
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$256,951,000.00
$86,000.00
Revenue This Year
$23.69
N/A
Revenue Next Year
$20.32
$1,002.94
P/E Ratio
N/A
N/A
Revenue Growth
32.90
N/A
52 Week Low
$15.52
$12.56
52 Week High
$28.47
$25.00

Technical Indicators

Market Signals
Indicator
SDGR
PLSE
Relative Strength Index (RSI) 29.52 49.53
Support Level $16.07 $13.82
Resistance Level $17.87 $15.34
Average True Range (ATR) 0.78 0.78
MACD -0.31 0.02
Stochastic Oscillator 2.11 28.88

Price Performance

Historical Comparison
SDGR
PLSE

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

Share on Social Networks: